Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S. V. Martirosyan"'
Autor:
A. L. Karpova, A. V. Mostovoi, S. V. Martirosyan, O. E. Orlova, L. N. Karpov, A. L. Zaplatnikov
Publikováno v:
Акушерство, гинекология и репродукция, Vol 17, Iss 3, Pp 366-375 (2023)
Neonatal sepsis still remains a serious problem of modern health care, being one of the main causes of neonatal and infant mortality, as well as disability in surviving children. Due to the high risk of adverse outcomes, the problem of early neonatal
Externí odkaz:
https://doaj.org/article/58910991b60a45cb92a7f3080e4a029b
Autor:
K. N. Grigoreva, N. R. Gashimova, V. O. Bitsadze, L. L. Pankratyeva, J. Kh. Khizroeva, M. V. Tretyakova, J.-C. Gris, A. E. Malikova, D. V. Blinov, V. I. Tsibizova, N. D. Degtyareva, S. V. Martirosyan, A. D. Makatsariya
Publikováno v:
Акушерство, гинекология и репродукция, Vol 17, Iss 1, Pp 127-137 (2023)
Advances in biology have allowed us to substantially deepen our knowledge about hemostasis functioning both in health and disease. ADAMTS-13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13) and von Willebrand factor (
Externí odkaz:
https://doaj.org/article/90292a0cce3842b49b9025288602f11e
Autor:
I. V. Feldblyum, V. V. Romanenko, A. M. Nikolaeva, K. A. Subbotina, O. Yu. Sosnina, O. A. Perminova, O. V. Belyakova, T. V. Danilina, A. E. Ershov, D. M. Trofimov, E. A. Bykova, S. V. Martirosyan, A. V. Ankudinova
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 2, Pp 68-75 (2018)
Aim. The aim of the study is evaluate of reactogenicity, safety and immunogenicity of the native combined vaccine DTaP-HepB+Hib. Materials and methods. Assessment of reactogenicity, safety and immunogenicity of the drug is investigated in a multicent
Externí odkaz:
https://doaj.org/article/fc96aa43e4914db495f2ad0106cc64da
Publikováno v:
Ural Medical Journal. 21:138-149
Introduction. The development of the information component of the health care system, as part of the social security system, is an inevitable process. Since 2018, the possibility of providing medical care using telemedicine technologies has been ensh